Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Issues»Volume 26, Issue 6»CUL4B/KLF11 axis promotes malignant ovarian cancer progression
    Volume 26, Issue 6

    CUL4B/KLF11 axis promotes malignant ovarian cancer progression

    December 1, 2021Updated:April 29, 20242 Mins Read
    Share
    Facebook Twitter Email

    Yapei Lu, Ziqi Cheng

    Department of Gynecology, The First Hospital of Hangzhou Fuyang, Hangzhou, China

    Summary

    Purpose: This study aimed to explore the role and the molecular mechanism of CUL4B in the occurrence and development of ovarian cancer (OC).

    Methods: The expressions of CUL4B in 20 pairs of OC tissue specimens and cell lines were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Subsequently, the CUL4B knockdown and overexpression models were constructed in OC cell lines SKOV3 and A2780 using lentivirus, respectively. Transwell and cell scratch assays were used to analyze the effect of CUL4B on OC cell function. Furthermore, luciferase reporter gene experiment and rescue experiments were performed to explore the potential mechanism of CUL4B and downstream gene KLF11.

    Results: The expressions of CUL4B in OC tissues were markedly higher than that of adjacent ones. Transwell and cell scratch experiments suggested that CUL4B overexpression markedly promoted the invasive and metastasis ability of OC cells. Bioinformatics and luciferase reporter gene experiments suggested that CUL4B could directly target KLF11. Rescue experiments indicated that KLF11 knockdown can reverse the inhibition of CUL4B silencing on OC cell migration and wound healing ability.

    Conclusions: CUL4B expression is markedly elevated in OC tissues and cell lines. CUL4B may negatively regulate the expression of KLF11, thereby enhancing the proliferative and metastatic ability of OC. In summary, CUL4B plays an important part in the progression of OC and might serve as a new potential target and prognostic indicator for ovarian cancer treatment.

    Keywords: CUL4B, KLF11, ovarian cancer, malignant progression.

    Full Text: PDF

    Original Article
    Previous ArticleThe best evidence for the prevention and management of lower extremity deep venous thrombosis after gynecological malignant tumor surgery: A systematic review and network meta-analysis
    Next Article Lidocaine for ovarian cancer. Preclinical in vitro data

    Related Articles

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    Volume 27, 2024

    Malignant Diseases as a Reason for Interventions by Emergency Medical Teams in Barajevo 2023

    Volume 27, 2024

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    Volume 26, Issue 6
    Don't Miss
    Volume 27, 2024

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Dimosthenis Chrysikos1, Spiros Delis2, Charina Triantopoulou2, Evgenia Charitaki2, Nikos Kokoroskos2, Nikolaos Taprantzis1*, Amir Shihada1, Konstantinos…

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025

    Abdominal Aortic Aneurysm and Radiation Therapy

    October 28, 2024
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.